Pharmaceutical Industry
NewslettersU.S. women need better birth control. So why is this contraceptive company ‘on life support?’
By Maria Aspan and Kinsey CrowleyApril 5, 2023
HealthA 79-year-old ‘white collar drug dealer’ who sold opioids to pharmacies is going to serve only 2 years in prison
By Bob Van Voris and BloombergMarch 8, 2023
By Helen Santoro and Kaiser Health NewsFebruary 27, 2023
By Darius Tahir and Kaiser Health NewsFebruary 17, 2023
HealthThe first drug to have even a limited impact on Alzheimer’s just got FDA approval. ‘This drug is not a cure.’
By Matthew Perrone and The Associated PressJanuary 6, 2023
HealthAlzheimer’s drug approval by FDA ‘rife with irregularities,’ Congress finds after 18-month investigation
By The Associated PressDecember 30, 2022
HealthALS patients face dilemma over drug’s $158K price tag: ‘I’m not going to spend all my money on this’
By Matthew Perrone and The Associated PressDecember 18, 2022
CommentaryCOVID, burnout, and drug shortages: Children and parents are paying the price for the medical system’s dysfunction
By Ellen DaSilvaDecember 15, 2022
By Arthur Allen and Kaiser Health NewsNovember 8, 2022
HealthU.S. considering its very first over-the-counter birth control pill: Here’s who’s on board and who isn’t
By Sophie MellorOctober 4, 2022
By Erin PraterSeptember 30, 2022
By Tristan BoveSeptember 12, 2022
Most Popular
